tiprankstipranks
Privia Health Group (PRVA)
NASDAQ:PRVA
US Market
Want to see PRVA full AI Analyst Report?

Privia Health Group (PRVA) Ratios

215 Followers

Privia Health Group Ratios

PRVA's free cash flow for Q1 2026 was $0.09. For the 2026 fiscal year, PRVA's free cash flow was decreased by $ and operating cash flow was $0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.61 1.60 1.86 1.81 2.09
Quick Ratio
1.61 1.60 1.86 1.81 2.09
Cash Ratio
0.70 0.84 1.09 1.01 1.32
Solvency Ratio
<0.01 0.06 0.05 0.08 -0.01
Operating Cash Flow Ratio
<0.01 0.29 0.24 0.21 0.18
Short-Term Operating Cash Flow Coverage
0.07 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 354.03B$ 332.57M$ 382.49M$ 308.29M$ 278.20M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 0.01
Debt-to-Equity Ratio
0.01 0.01 <0.01 0.01 0.02
Debt-to-Capital Ratio
0.01 0.01 <0.01 0.01 0.02
Long-Term Debt-to-Capital Ratio
<0.01 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.88 1.86 1.79 1.78 1.59
Debt Service Coverage Ratio
0.02 0.00 0.00 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
3.08 0.00 0.00 0.00 0.00
Interest Debt Per Share
72.66 0.08 0.05 0.07 0.10
Net Debt to EBITDA
-7.83K -10.65 -20.02 -14.02 23.12
Profitability Margins
Gross Profit Margin
9.59%9.87%10.19%9.74%9.93%
EBIT Margin
1.83%1.61%0.98%1.25%-1.41%
EBITDA Margin
2.33%2.08%1.40%1.64%-1.07%
Operating Profit Margin
1.62%1.61%0.98%1.25%-1.41%
Pretax Profit Margin
2.01%2.07%1.61%1.75%-1.37%
Net Profit Margin
0.97%1.08%0.83%1.39%-0.63%
Continuous Operations Profit Margin
1.22%1.40%0.98%1.27%-0.89%
Net Income Per EBT
48.26%52.16%51.61%79.53%46.21%
EBT Per EBIT
123.77%128.34%164.11%140.54%97.17%
Return on Assets (ROA)
<0.01%1.67%1.27%2.31%-1.08%
Return on Equity (ROE)
0.01%3.11%2.26%4.11%-1.72%
Return on Capital Employed (ROCE)
<0.01%4.27%2.47%3.37%-3.62%
Return on Invested Capital (ROIC)
<0.01%2.88%1.51%2.43%-2.34%
Return on Tangible Assets
<0.01%2.43%1.63%3.06%-1.41%
Earnings Yield
0.76%0.79%0.62%0.86%-0.34%
Efficiency Ratios
Receivables Turnover
<0.01 5.30 5.49 5.70 7.16
Payables Turnover
3.84 239.99 159.87 189.83 181.53
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.26 228.31 286.06 185.49 118.23
Asset Turnover
<0.01 1.55 1.53 1.66 1.71
Working Capital Turnover Ratio
0.01 5.83 4.96 5.51 4.99
Cash Conversion Cycle
83.36K 67.41 64.18 62.10 49.00
Days of Sales Outstanding
83.46K 68.93 66.46 64.02 51.01
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
95.11 1.52 2.28 1.92 2.01
Operating Cycle
83.46K 68.93 66.46 64.02 51.01
Cash Flow Ratios
Operating Cash Flow Per Share
1.11 1.34 0.92 0.69 0.43
Free Cash Flow Per Share
1.10 1.33 0.87 0.69 0.43
CapEx Per Share
<0.01 <0.01 0.04 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.99 0.99 0.95 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
112.56 136.17 21.76 714.91 453.81
Capital Expenditure Coverage Ratio
112.56 136.17 21.76 714.91 453.81
Operating Cash Flow Coverage Ratio
0.02 17.14 19.55 9.75 4.10
Operating Cash Flow to Sales Ratio
0.06 0.08 0.06 0.05 0.03
Free Cash Flow Yield
4.71%5.60%4.47%3.00%1.87%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
132.58 126.39 162.27 116.48 -292.82
Price-to-Sales (P/S) Ratio
1.30 1.36 1.34 1.62 1.85
Price-to-Book (P/B) Ratio
<0.01 3.93 3.68 4.79 5.04
Price-to-Free Cash Flow (P/FCF) Ratio
21.41 17.86 22.39 33.32 53.38
Price-to-Operating Cash Flow Ratio
20.91 17.73 21.36 33.28 53.26
Price-to-Earnings Growth (PEG) Ratio
3.45 2.17 -4.06 -0.41 3.12
Price-to-Fair Value
<0.01 3.93 3.68 4.79 5.04
Enterprise Value Multiple
-7.78K 54.97 76.24 84.88 -149.64
Enterprise Value
-407.60B 2.43B 1.85B 2.31B 2.18B
EV to EBITDA
-7.78K 54.97 76.24 84.88 -149.64
EV to Sales
-181.43 1.14 1.06 1.39 1.60
EV to Free Cash Flow
-2.98K 14.96 17.73 28.60 46.24
EV to Operating Cash Flow
-2.95K 14.85 16.92 28.56 46.14
Tangible Book Value Per Share
3.09K 2.99 3.62 3.09 3.02
Shareholders’ Equity Per Share
6.07K 6.03 5.32 4.81 4.51
Tax and Other Ratios
Effective Tax Rate
0.39 0.32 0.39 0.28 0.35
Revenue Per Share
18.10 17.38 14.54 14.20 12.26
Net Income Per Share
0.18 0.19 0.12 0.20 -0.08
Tax Burden
0.48 0.52 0.52 0.80 0.46
Interest Burden
1.10 1.28 1.64 1.41 0.97
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
22.14 0.08 0.09 0.07 0.10
Stock-Based Compensation to Revenue
<0.01 0.00 0.00 0.00 0.05
Income Quality
6.17 7.13 7.60 3.50 -3.91
Currency in USD